{"doi":"10.1038/s41375-021-01213-5","title":"Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR","abstract":"Optimal post-remission therapy for adolescents and young adults (AYAs) with Ph-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR1) is not established. We compared overall survival (OS), disease-free survival (DFS), relapse, and non-relapse mortality (NRM) for patients receiving post-remission therapy on CALGB 10403 to a cohort undergoing myeloablative (MA) allogeneic hematopoietic cell transplantation (HCT) in CR1. In univariate analysis, OS was superior with chemotherapy compared to MA allogeneic HCT (3-year OS 77% vs. 53%, P < 0.001). In multivariate analysis, allogeneic HCT showed inferior OS (HR 2.00, 95% CI 1.5-2.66, P < 0.001), inferior DFS (HR 1.62, 95% CI 1.25-2.12, P < 0.001), and increased NRM (HR 5.41, 95% CI 3.23-9.06, P < 0.001) compared to chemotherapy. A higher 5-year relapse incidence was seen with chemotherapy compared to allogeneic HCT (34% vs. 23%, P = 0.011). Obesity was independently associated with inferior OS (HR 2.17, 95% CI 1.63-2.89, P < 0.001), inferior DFS (HR 1.97, 95% CI 1.51-2.57, P < 0.001), increased relapse (1.84, 95% CI 1.31-2.59, P < 0.001), and increased NRM (HR 2.10, 95% CI 1.37-3.23, P < 0.001). For AYA ALL patients in CR1, post-remission therapy with pediatric-style chemotherapy is superior to MA allogeneic HCT for OS, DFS, and NRM.","journal":"Leukemia","year":2021,"id":159197,"datarank":0.5641800173540344,"base_score":3.7612001156935624,"endowment":3.7612001156935624,"self_citation_contribution":0.5641800173540344,"citation_network_contribution":0.0,"self_endowment_contribution":0.5641800173540344,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":42,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9547,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":230930,"name":"Wendy Stock","orcid":"0000-0002-8349-9200","position":1,"is_corresponding":false},{"id":233352,"name":"Anjali S. Advani","orcid":"0000-0003-0015-5902","position":2,"is_corresponding":false},{"id":284260,"name":"Selina M. Luger","orcid":"0000-0003-3364-4366","position":3,"is_corresponding":false},{"id":305983,"name":"Richard A. Larson","orcid":"0000-0001-9168-3203","position":4,"is_corresponding":false},{"id":108822,"name":"Martin S. Tallman","orcid":"0000-0002-4367-6102","position":5,"is_corresponding":false},{"id":3639,"name":"Frederick R. Appelbaum","orcid":"0000-0002-1839-5069","position":6,"is_corresponding":false},{"id":313258,"name":"Mei-Jie Zhang","orcid":null,"position":7,"is_corresponding":false},{"id":670166,"name":"Khalid Bo-Subait","orcid":null,"position":8,"is_corresponding":false},{"id":340919,"name":"Hai-Lin Wang","orcid":null,"position":9,"is_corresponding":false},{"id":284263,"name":"Vijaya Raj Bhatt","orcid":"0000-0003-2513-0533","position":10,"is_corresponding":false},{"id":521113,"name":"Bhagirathbhai Dholaria","orcid":"0000-0003-2371-3655","position":11,"is_corresponding":false},{"id":122964,"name":"Mary Eapen","orcid":"0000-0001-6193-4243","position":12,"is_corresponding":false},{"id":122965,"name":"Mehdi Hamadani","orcid":"0000-0001-5372-510X","position":13,"is_corresponding":false},{"id":669489,"name":"Omer Jamy","orcid":"0000-0003-2411-4742","position":14,"is_corresponding":false},{"id":285768,"name":"Tim Prestidge","orcid":"0000-0003-4078-5001","position":15,"is_corresponding":false},{"id":263463,"name":"Michael A. Pulsipher","orcid":"0000-0003-3030-8420","position":16,"is_corresponding":false},{"id":669490,"name":"David Ritchie","orcid":"0000-0002-9844-8350","position":17,"is_corresponding":false},{"id":339795,"name":"David A. Rizzieri","orcid":"0000-0001-9886-5771","position":18,"is_corresponding":false},{"id":313730,"name":"Akshay Sharma","orcid":"0000-0003-3281-2081","position":19,"is_corresponding":false},{"id":669491,"name":"Pere Barba","orcid":"0000-0003-1038-5197","position":20,"is_corresponding":false},{"id":236728,"name":"Brenda M. Sandmaier","orcid":"0000-0002-9767-9739","position":21,"is_corresponding":false},{"id":339781,"name":"Marcos de Lima","orcid":"0000-0002-8568-4522","position":22,"is_corresponding":false},{"id":104772,"name":"Partow Kebriaei","orcid":"0000-0002-8607-9404","position":23,"is_corresponding":false},{"id":284142,"name":"Mark R. Litzow","orcid":"0000-0002-9816-6302","position":24,"is_corresponding":false},{"id":122972,"name":"Wael Saber","orcid":"0000-0002-6544-5815","position":25,"is_corresponding":false},{"id":122976,"name":"Daniel J. Weisdorf","orcid":"0000-0001-8078-8579","position":26,"is_corresponding":false},{"id":233351,"name":"Matthew J. Wieduwilt","orcid":"0000-0002-5414-9228","position":0,"is_corresponding":true}],"reference_count":36,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-18T23:44:35.165422Z","pmid":"33785862","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}